These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2505074)
1. Streptokinase or tissue plasminogen activator and left ventricular function after myocardial infarction. N Engl J Med; 1989 Sep; 321(10):687-9. PubMed ID: 2505074 [No Abstract] [Full Text] [Related]
3. The effects of streptokinase and tissue plasminogen activator on left ventricular function. White HD Adv Exp Med Biol; 1990; 281():383-7. PubMed ID: 2129375 [No Abstract] [Full Text] [Related]
4. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. White HD; Rivers JT; Maslowski AH; Ormiston JA; Takayama M; Hart HH; Sharpe DN; Whitlock RM; Norris RM N Engl J Med; 1989 Mar; 320(13):817-21. PubMed ID: 2494454 [TBL] [Abstract][Full Text] [Related]
5. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction. Mock MB; Chesebro JH Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892 [No Abstract] [Full Text] [Related]
6. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?]. Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353 [TBL] [Abstract][Full Text] [Related]
8. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase. Massel D Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776 [TBL] [Abstract][Full Text] [Related]
9. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496 [No Abstract] [Full Text] [Related]
10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799 [TBL] [Abstract][Full Text] [Related]
11. What you should know about thrombolytic therapy for acute MI. Aragon D; Martin M Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959 [No Abstract] [Full Text] [Related]
12. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?]. Negrini M G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921 [No Abstract] [Full Text] [Related]
14. [Tissue plasminogen activator is the best thrombolytic agent]. Bates E Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215 [No Abstract] [Full Text] [Related]
15. [Acute myocardial infarction: what thrombolytic agent should be chosen?]. Sandøe E Ugeskr Laeger; 1991 Oct; 153(41):2879. PubMed ID: 1949300 [No Abstract] [Full Text] [Related]
16. Reduction of left ventricular damage with intracoronary streptokinase in acute myocardial infarction. de Feyter PJ; van Eenige MJ; van der Wall EE Postgrad Med J; 1983; 59 Suppl 3():107-11. PubMed ID: 6647196 [TBL] [Abstract][Full Text] [Related]
17. [GISSI-2; the beginning of the end or the end of the beginning for tissue plasminogen activator in acute myocardial infarct?]. Lubsen J Ned Tijdschr Geneeskd; 1990 May; 134(19):940-4. PubMed ID: 2112233 [No Abstract] [Full Text] [Related]